Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001437749-12-013038
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-20 14:27:46
Reporting Period:
2012-12-13
Filing Date:
2012-12-20
Filing Date Changed:
2012-12-20
Accepted Time:
2012-12-20 14:27:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
894237 Vision Sciences Inc VSCI Electromedical & Electrotherapeutic Apparatus (3845) 133430173
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901507 C Lewis Pell C/o Vision-Sciences, Inc.
40 Ramland Road South, Suite 1
Orangeburg NY 10962
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $0.01 Par Value Per Share Acquisiton 2012-12-13 2,800 $1.10 8,939,631 No 4 P Direct
Common Stock $0.01 Par Value Per Share Acquisiton 2012-12-14 5,600 $1.10 7,945,231 No 4 P Direct
Common Stock $0.01 Par Value Per Share Acquisiton 2012-12-17 13,200 $1.11 7,958,431 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock $0.01 Par Value Per Share 50,000 Indirect By spouse
Common Stock $0.01 Par Value Per Share 43,500 Indirect By trust
Footnotes
  1. Weighted average purchase price for common stock acquired. Actual purchase price for shares acquired ranged from $1.10 to $1.1189. The Company undertakes to provide upon request to the Staff of the SEC, the issuer or security holder full information regarding the number of shares purchased at each separate price.